Skip to main content
main-content

Improving the management of hepatocellular carcinoma

BEST PRACTICE AND FUTURE DIRECTIONS

A multimedia educational report for HCPs managing liver cancer patients

Access this scientific summary report to enhance your knowledge and understanding of the current landscape of hepatocellular carcinoma (HCC) treatment and emerging therapies that could offer the possibility for individualized treatment.

Videos and written summaries of presentations from liver cancer experts Andrew Zhu, Peter Galle, and Richard Finn survey current standards of care and new treatment strategies for HCC. The report includes case studies to illustrate how to translate evidence into practice.

Topics include:

  • HCC pathophysiology and diagnosis, including tumor–microenvironment interactions
  • Optimal sequencing of TKIs and immunotherapy
  • The challenges of 3rd line HCC treatment and beyond
  • TKI and immunotherapy combination approaches

The presentations took place at an independent satellite symposium at ILCA 2019. Access the symposium details and take-home messages from the Faculty.

You can also watch the full webcast of the symposium.

Faculty


Educational grant

This activity is supported by an education grant from Eli Lilly and Company.

Contact us

Springer Healthcare IME.
The Campus, 4 Crinan Street
London, N1 9XW, UK
Email: IME@springer.com
Telephone +44 (0) 203 192 2023

Image Credits